Trials / Completed
CompletedNCT00377273
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is being undertaken to: 1. assess the safety of fluorouracil cream for the treatment of actinic keratoses ("AKs") on other common skin surface areas (e.g., posterior scalp, ears, neck, lips, arms and hands); 2. collect additional post-treatment safety data on fluorouracil cream applied to the face (including anterior scalp, if applicable); 3. assess the incidence of recurrence of AKs on the face; and 4. assess the need for re-treatment with fluorouracil cream to the face.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluorouracil cream 0.5% |
Timeline
- Start date
- 2003-11-01
- Completion
- 2005-10-01
- First posted
- 2006-09-18
- Last updated
- 2008-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00377273. Inclusion in this directory is not an endorsement.